Literature DB >> 12706261

Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion.

Boryana K Popivanova1, Koji Koike, Anton B Tonchev, Yuko Ishida, Toshikazu Kondo, Satoshi Ogawa, Naofumi Mukaida, Masaki Inoue, Tetsumori Yamashima.   

Abstract

ELR(+) CXC chemokines including IL-8 are known to be involved in the ischemia-reperfusion injuries in various organs including rodent brain. However, the roles of these chemokines during the ischemia-reperfusion injuries of the primate brain still remain unknown. Here, we studied expressions of CXC chemokines and their receptor CXCR2 in monkey hippocampus known to develop total CA1 neuronal loss on day 5 after 20-min ischemia and reperfusion. ELR(+) chemokines and their receptor CXCR2 were not detected in the hippocampus of non-ischemic monkeys. On the contrary, at 30-60 min after the start of reperfusion, CD68-positive microglial cells increased significantly in the hippocampal CA1 sector, but there was negligible infiltration of neutrophils. These microglial cells expressed simultaneously growth regulated oncogene (Gro)-alpha and other ELR(+) CXC chemokines. Moreover, CD68-positive microglial cells also expressed the receptor for ELR(+) CXC chemokines. On day 4, capillary endothelial cells were significantly increased in the CA1 sector. Considering that ELR(+) CXC chemokines have potent angiogenic activities, the coordinate expression of ELR(+) CXC chemokines and their receptor CXCR2 in microglial cells may be related not only to the ischemic brain injuries but also to the microglial and capillary proliferation in the monkey hippocampus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706261     DOI: 10.1016/s0006-8993(03)02343-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

2.  Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2.

Authors:  De-Li Cao; Zhi-Jun Zhang; Rou-Gang Xie; Bao-Chun Jiang; Ru-Rong Ji; Yong-Jing Gao
Journal:  Exp Neurol       Date:  2014-05-20       Impact factor: 5.330

Review 3.  Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.

Authors:  Zhi-Jun Zhang; Bao-Chun Jiang; Yong-Jing Gao
Journal:  Cell Mol Life Sci       Date:  2017-04-07       Impact factor: 9.261

4.  Inflammation in adult and neonatal stroke.

Authors:  Zinaida S Vexler; Xian Nan Tang; Midori A Yenari
Journal:  Clin Neurosci Res       Date:  2006-12-01

5.  Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion.

Authors:  Christine Fox; Andra Dingman; Nikita Derugin; Michael F Wendland; Catherine Manabat; Shaoquan Ji; Donna M Ferriero; Zinaida S Vexler
Journal:  J Cereb Blood Flow Metab       Date:  2005-09       Impact factor: 6.200

6.  CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination.

Authors:  Martin P Hosking; Emanuele Tirotta; Richard M Ransohoff; Thomas E Lane
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

Review 7.  Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.

Authors:  Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2008-12-16       Impact factor: 2.801

8.  CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-kappaB (NFkappaB) and activator protein-1 (AP-1).

Authors:  Teresa G D'Aversa; Eliseo A Eugenin; Joan W Berman
Journal:  J Neurosci Res       Date:  2008-02-15       Impact factor: 4.164

9.  JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1.

Authors:  Zhong-Liang Wang; Ting-Ting Du; Rui-Guang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

Review 10.  The chemokine receptor CXCR2 and coronavirus-induced neurologic disease.

Authors:  Jason G Weinger; Brett S Marro; Martin P Hosking; Thomas E Lane
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.